Good Shepherd Glenn-garrett Clinic - Jefferson Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 903 N Walcott St, Jefferson, TX 75657 Phone: 903-665-9500 Fax: 903-665-9501 |
Jefferson Life Center Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 219 N Polk St, Jefferson, TX 75657 Phone: 903-247-0484 Fax: 903-247-0485 |
East Texas Border Health Clinic Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 106 N Alley Street, Jefferson, TX 75657 Phone: 903-665-8453 Fax: 903-665-8496 |
Jefferson Family Health Center Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 106 N Alley St, Jefferson, TX 75657 Phone: 903-665-1014 |
News Archive
The Multiple Myeloma Research Consortium (MMRC) today announced that it has expanded its clinical research network to include Baylor Charles A. Sammons Cancer Center (Dallas, TX), Sarah Cannon /Research Institute (SCRI, Nashville, TN) and Virginia Cancer Specialists (Fairfax, VA). These new centers join the 13 existing MMRC Member Institutions in promoting and facilitating collaborative research and accelerating drug development in multiple myeloma, an incurable blood cancer.
A University of Manchester study which looked at more than thirty years of research into bipolar, found that people with the disorder are 2.63 times more likely to have suffered emotional, physical or sexual abuse as children than the general population.
Eating a diet higher in saturated fat, a type of fat found commonly in foods such as fatty beef and cheese, was linked to more aggressive prostate cancer, a study by University of North Carolina Lineberger Comprehensive Cancer Center researchers and collaborators has found. The preliminary results were presented Monday, April 18 at the American Association for Cancer Research Annual Meeting in New Orleans.
Investigators at St. Jude Children's Research Hospital have discovered inherited variations in certain genes that make children with acute lymphoblastic leukemia (ALL) susceptible to the toxic side effects caused by chemotherapy medications.
Scientists have discovered a biological marker that may help to identify which depressed patients will respond to an experimental, rapid-acting antidepressant. The brain signal, detectable by noninvasive imaging, also holds clues to the agent's underlying mechanism, which are vital for drug development, say National Institutes of Health researchers.
› Verified 5 days ago